Coimbatore Ayurveda Crntre (CAC), branch of the prestigious Arya Vaidya Pharmacy, Coimbatore opened its fifth branch in Ma’abela in Muscat
The Ayurvedic treatment proved more relevant during the Covid-19 pandemic. It established its relevance strongly during the pandemic because it not only healed Covid-19 patients; it kept totally safe those who took preventive Ayurvedic medicines
Residents of Muscat are lucky to have yet another Ayurveda centre in the city that too a branch of prestigious Arya Vaidya Pharmacy (AVP), Coimbatore, Tamil Nadu. The AAP’s Coimbatore Ayurveda Crntre (CAC) branch opened its fifth branch in Ma’abela in Muscat, Oman.
The CAC strives to expand and open an in-patient service hospital for long term treatments and add four more centres across Oman in the period of next five years.
The CAC had begun its operations in Oman in 2008 when Babu Kolora, Managing Director of Coimbatore Ayurveda Centre, felt an urge to bring the Ayurvedic therapies practised by Arya Vaidya Pharmacy in Coimbatore to Muscat. The CEO, Bijesh Kolora said in the last 14 years the CAC clinics have achieved a high success rate by combating various normal and complicated diseases.
“We have achieved positive results in the management of post stroke conditions, rheumatoid arthritis and intervertebral disc prolapse (IVDP).”
The Arya Vaidya Pharmacy (Coimbatore) Limited was established in 1943 by Arya Vaidyan P V Rama Varier, a renowned physician who was trained in the age old Ayurveda tradition of Kerala.
The AVP has been engaged in manufacturing and marketing of Ayurvedic medicines, treatments in India, franchise centers in Oman and Malaysia, education, research and medicinal plant conservation and cultivation.
The AVP has also been keen on infusing modern technology and concepts to the ancient science of Ayurveda to meet the challenges posed by modern world. The company has been exporting products to 25 countries including Oman, the United Arab Emirates, Malaysia, USA and Australia in addition to international brands.
The Managing Director of AVP, C Devdas Varier, explained that the AVP has undertaken Covid-19 preventive and management care during the peak of the pandemic, reaching out to the Covid-19 care camps and affected areas with free distribution of medications.
“Our medicines proved to be effective in reducing the severity of the disease,” he noted.
The Ministry of Ayush, Government of India, granted funds for clinical research on management of Covid-19 through classical Ayurveda and the study proved that Ayurvedic treatment gives effective relief to patients.
Varier pointed out that the Government of India has come forward to fund the first ever multi centric phase 3 clinical trial on the efficacy of Ayurveda in the management of rheumatoid arthritis.
“The study would be in collaboration with the Central Council for Research in Ayurveda and designed by the world renowned rheumatologist Dr Daniel Furst, currently the director of clinical research at Arthritis Association of South California (AASC). This study is a follow up of the earlier pilot study conducted by AVP in 2003 granted by National Institutes of Health, USA through the University of Washington, Seattle, USA,” explained Varier.
**********************************************************************
Readers
These are extraordinary times. All of us have to rely on high-impact, trustworthy journalism. And this is especially true of the Indian Diaspora. Members of the Indian community overseas cannot be fed with inaccurate news.
Pravasi Samwad is a venture that has no shareholders. It is the result of an impassioned initiative of a handful of Indian journalists spread around the world. We have taken the small step forward with the pledge to provide news with accuracy, free from political and commercial influence. Our aim is to keep you, our readers, informed about developments at ‘home’ and across the world that affect you.
Please help us to keep our journalism independent and free.
In these difficult times, to run a news website requires finances. While every contribution, big or small, will makes a difference, we request our readers to put us in touch with advertisers worldwide. It will be a great help.
For more information: pravasisamwad00@gmail.com